Literature DB >> 35111879

Differences in Health-Related Outcomes and Health Care Resource Utilization in Breast Cancer Survivors With and Without Type 2 Diabetes.

Susan Storey1, Zuoyi Zhang2, Xiao Luo3, Megan Metzger4, Amrutha Ravali Jakka3, Kun Huang2, Diane Von Ah1.   

Abstract

PURPOSE: Up to 74% of breast cancer survivors (BCS) have at least one preexisting comorbid condition, with diabetes (type 2) common. The purpose of this study was to examine differences in health-related outcomes (anemia, neutropenia, and infection) and utilization of health care resources (inpatient, outpatient, and emergency visits) in BCS with and without diabetes.
METHODS: In this retrospective cohort study, data were leveraged from the electronic health records of a large health network linked to the Indiana State Cancer Registry. BCS diagnosed between January 2007 and December 2017 and who had received chemotherapy were included. Multivariable logistic regression and generalized linear models were used to determine differences in health outcomes and health care resources.
RESULTS: The cohort included 6851 BCS, of whom 1121 (16%) had a diagnosis of diabetes. BCS were, on average, 55 (standard deviation: 11.88) years old, the majority self-reported race as White (90%), and 48.8% had stage II breast cancer. BCS with diabetes were significantly older (mean age of 60.6 [SD: 10.34] years) than those without diabetes and were often obese (66% had body mass index of ≥33). BCS with diabetes had higher odds of anemia (odds ratio: 1.43; 95% CI: 1.04, 1.96) and infection (odds ratio: 1.86; 95% CI: 1.35, 2.55) and utilized more outpatient resources (P<0.0001).
CONCLUSIONS: Diabetes has a deleterious effect on health-related outcomes and health care resource utilization among BCS. These findings support the need for clinical practice guidelines to help clinicians manage diabetes among BCS throughout the cancer trajectory and for coordinated models of care to reduce high resource utilization.
© 2022 Aurora Health Care, Inc.

Entities:  

Keywords:  breast cancer; electronic health records; health care utilization; health-related outcomes; survivorship; type 2 diabetes

Year:  2022        PMID: 35111879      PMCID: PMC8772606          DOI: 10.17294/2330-0698.1862

Source DB:  PubMed          Journal:  J Patient Cent Res Rev        ISSN: 2330-068X


  34 in total

1.  Economic burden of cancer in the United States: estimates, projections, and future research.

Authors:  K Robin Yabroff; Jennifer Lund; Deanna Kepka; Angela Mariotto
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-10       Impact factor: 4.254

2.  Diabetes and other comorbidities in breast cancer survival by race/ethnicity: the California Breast Cancer Survivorship Consortium (CBCSC).

Authors:  Anna H Wu; Allison W Kurian; Marilyn L Kwan; Esther M John; Yani Lu; Theresa H M Keegan; Scarlett Lin Gomez; Iona Cheng; Salma Shariff-Marco; Bette J Caan; Valerie S Lee; Jane Sullivan-Halley; Chiu-Chen Tseng; Leslie Bernstein; Richard Sposto; Cheryl Vigen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-11-25       Impact factor: 4.254

Review 3.  Obesity and the risk and outcome of infection.

Authors:  R Huttunen; J Syrjänen
Journal:  Int J Obes (Lond)       Date:  2012-05-01       Impact factor: 5.095

4.  Risk factors for surgical site infection after major breast operation.

Authors:  Margaret A Olsen; Mellani Lefta; Jill R Dietz; Keith E Brandt; Rebecca Aft; Ryan Matthews; Jennie Mayfield; Victoria J Fraser
Journal:  J Am Coll Surg       Date:  2008-06-26       Impact factor: 6.113

5.  Neutropenia: occurrence and management in women with breast cancer receiving chemotherapy.

Authors:  Talita Garcia do Nascimento; Marceila de Andrade; Rosemeire Aparecida de Oliveira; Ana Maria de Almeida; Thais de Oliveira Gozzo
Journal:  Rev Lat Am Enfermagem       Date:  2014 Mar-Apr

6.  Impact of preoperative anemia on relapse and survival in breast cancer patients.

Authors:  YingJun Zhang; YuYang Chen; DongTai Chen; Yu Jiang; Wan Huang; HanDong Ouyang; Wei Xing; MuSheng Zeng; XiaoMing Xie; Weian Zeng
Journal:  BMC Cancer       Date:  2014-11-18       Impact factor: 4.430

7.  Effect of Age on Breast Cancer Patient Prognoses: A Population-Based Study Using the SEER 18 Database.

Authors:  Hai-Long Chen; Mei-Qi Zhou; Wei Tian; Ke-Xin Meng; Hai-Fei He
Journal:  PLoS One       Date:  2016-10-31       Impact factor: 3.240

Review 8.  Inflamm-Aging of Hematopoiesis, Hematopoietic Stem Cells, and the Bone Marrow Microenvironment.

Authors:  Larisa V Kovtonyuk; Kristin Fritsch; Xiaomin Feng; Markus G Manz; Hitoshi Takizawa
Journal:  Front Immunol       Date:  2016-11-14       Impact factor: 7.561

9.  Key metabolic parameters change significantly in early breast cancer survivors: an explorative PILOT study.

Authors:  Stine Overvad Fredslund; Claus Højbjerg Gravholt; Britt Elmedal Laursen; Anders Bonde Jensen
Journal:  J Transl Med       Date:  2019-04-01       Impact factor: 5.531

Review 10.  Managing breast cancer in younger women: challenges and solutions.

Authors:  Foluso O Ademuyiwa; Amy Cyr; Jennifer Ivanovich; Maria A Thomas
Journal:  Breast Cancer (Dove Med Press)       Date:  2015-12-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.